Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine TumorGiuseppe Lamberti, Davide Campana, Maria Pia Brizzi et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 41
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS groupAnnamaria Colao, Antongiulio Faggiano, Silvana Di Maio et al.|Endocrine|2019Cited by 35
55 THE HIGH INCIDENCE OF LUNG CANCER IN A GENERAL HOSPITAL: A RETROSPECTIVE SINGLE-INSTITUTION ANALYSIS IN 2009Danilo Rocco, Ferdinando Riccardi, Irena Ruggiero et al.|Cancer Treatment Reviews|2010Cited by 0